{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T18:06:12Z","timestamp":1774634772819,"version":"3.50.1"},"reference-count":7,"publisher":"BMJ","issue":"9","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,8,14]]},"published-print":{"date-parts":[[2020,9]]},"abstract":"<jats:p>Recent studies have shown that BRAF inhibitors, such as vemurafenib, are effective in inducing long periods of remission in relapsed hairy cell leukaemia. Acute pancreatitis is one of the rare complications that is reported with vemurafenib use. As severe pancreatitis can be life threatening, physicians should be vigilant of this side effect and promptly treat patients that develop clinical signs and symptoms while receiving vemurafenib. We present an interesting case of vemurafenib-induced pancreatitis that not only resolved but also did not recur after reintroduction of the drug at a reduced dose.<\/jats:p>","DOI":"10.1136\/bcr-2020-236073","type":"journal-article","created":{"date-parts":[[2020,9,14]],"date-time":"2020-09-14T17:16:18Z","timestamp":1600103778000},"page":"e236073","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Vemurafenib-induced pancreatitis in a patient with recurrent hairy cell leukaemia"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6741-8741","authenticated-orcid":false,"given":"Su Yun","family":"Chung","sequence":"first","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Northwell Health, Manhasset, New York, USA"},{"name":"Northwell Cancer Institute, Hematology\/Medical Oncology, Monter Cancer Center, Lake Success, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janice Gloria","family":"Shen","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Northwell Health, Manhasset, New York, USA"},{"name":"Northwell Cancer Institute, Hematology\/Medical Oncology, Monter Cancer Center, Lake Success, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina M","family":"Ghiuzeli","sequence":"additional","affiliation":[{"name":"Division of Hematology-Oncology, Department of Medicine, Northwell Health, Manhasset, New York, USA"},{"name":"Northwell Cancer Institute, Hematology\/Medical Oncology, Monter Cancer Center, Lake Success, New York, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,9,14]]},"reference":[{"key":"2025082723102679000_13.9.e236073.1","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/ajh.24936","article-title":"Hairy cell leukemia 2018: update on diagnosis, risk-stratification, and treatment","volume":"92","author":"Troussard","year":"2017","journal-title":"Am J Hematol"},{"key":"2025082723102679000_13.9.e236073.2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1002\/hon.2594","article-title":"New treatment options in hairy cell leukemia with focus on BRAF inhibitors","volume":"37 Suppl 1","author":"Falini","year":"2019","journal-title":"Hematol Oncol"},{"key":"2025082723102679000_13.9.e236073.3","doi-asserted-by":"publisher","DOI":"10.1002\/phar.1208"},{"key":"2025082723102679000_13.9.e236073.4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1014209"},{"key":"2025082723102679000_13.9.e236073.5","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1506583"},{"key":"2025082723102679000_13.9.e236073.6","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-680074"},{"key":"2025082723102679000_13.9.e236073.7","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.12788\/jcso.0347","article-title":"Pancreatitis associated with newer classes of antineoplastic therapies","volume":"15","author":"Clamon","year":"2017","journal-title":"J Community Support Oncol"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-236073","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T06:10:34Z","timestamp":1756361434000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-236073"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":7,"journal-issue":{"issue":"9","published-online":{"date-parts":[[2020,9,14]]},"published-print":{"date-parts":[[2020,9]]}},"alternative-id":["10.1136\/bcr-2020-236073"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-236073","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,9]]}}}